Download PDF
1 / Pages

Other users also viewed these articles

Ustekinumab in Crohn's disease: Effectiveness and safety in clinical practice Cristina Saldaña Dueñas; María Rullán Iriarte; Alfonso Elosua González; Cristina Rodríguez Gutiérrez; Saioa Rubio Iturria; Óscar Nantes Castillejo;
Gastroenterol Hepatol. 2020;43:497-505
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn¿s Disease and Ulcerative Colitis Francisco Rodríguez-Moranta; Federico Argüelles-Arias; Joaquín Hinojosa del Val; Marisa Iborra Colomino; M. Dolores Martín-Arranz; Luis Menchén Viso; Fernando Muñoz Núñez; Elena Ricart Gómez; José Germán Sánchez-Hernández; Teresa Valdés-Delgado; Jordi Guardiola Capón; Manuel Barreiro-de Acosta; Míriam Mañosa Ciria; Yamile Zabana Abdo; Ana Gutiérrez Casbas;
Gastroenterol Hepatol. 2024;47:522-52
Translation into Spanish and validation of a short questionnaire to measure the control of inflammatory bowel disease from the patient's perspective: IBD-Control, EII-Control Raquel Vicente Lidón; Santiago García López; Pilar Corsino Roche; José Miguel Boudet Barraca; Patricia Sanz Segura; Paula García Cámara; Eva Sierra Moros; Fernando Gomollón García;
Gastroenterol Hepatol. 2022;45:524-34